Gland Pharma Ltd.

NSE: GLAND  SECTOR: Pharmaceuticals & Drugs

2108.95
+54.5 (2.65%)

Price Summary

Today's High

₹ 2157

Today's Low

₹ 2056.5

52 Week High

₹ 2221.8

52 Week Low

₹ 1701

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.

Company Essentials

Market Cap

34435.530956585 Cr.

Enterprise Value

33115.297956585 Cr.

No. of Shares

16.3282823 Cr.

P/E

44.56

P/B

3.41

Face Value

₹ 1

Div. Yield

0%

Book Value (TTM)

₹  618.9144

CASH

1325.193 Cr.

DEBT

4.96 Cr.

Promoter Holding

0%

EPS (TTM)

₹  47.3325

Sales Growth

28.8149953796174%

ROE

23.8100490090365 %

ROCE

30.6819754193948 %

Profit Growth

29.3500782306208 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1w1m3m6m1Yr3Yr5Yr

* Prices are based on daily market changes.

Valuation Chart 1w1m3m6m1Yr3Yr5Yr

* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Sales Growth (in Cr.)

1 Year28.81%
3 Year21.2%
5 Year21.52%

Profit Growth (in Cr.)

1 Year71.02%
3 Year23.16%
5 Year29.86%

ROE%

1 Year23.81%
3 Year18.41%
5 Year19.52%

ROCE %

1 Year30.68%
3 Year26.4%
5 Year27.52%

Debt/Equity

0.0014

Price to Cash Flow

49.13

Interest Cover Ratio

139.243664717349

CFO/PAT (5 Yr. Avg.)

0.762298628335693

Share Holding Pattern

Share Holding Data is not available for this company.
Report us
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 23.1579063663838% for the Past 3 years.
  • The company has shown a good revenue growth of 21.1963002618893% for the Past 3 years.
  • Company has been maintaining healthy ROCE of 26.4027551432653% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 139.243664717349.
  • The Company has been maintaining an effective average operating margins of 36.5411851896229% in the last 5 years.
  • Company has a healthy liquidity position with current ratio of 7.92787648702172.
  • The company has a good cash flow management; CFO/PAT stands at 0.762298628335693.

 Limitations

  • The company is trading at a high EV/EBITDA of 30.2524.

Quarterly Result (All Figures in Cr.)

Quaterly Data is not available for this company.
Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales 1347.87 1479.18 1619.94 2044.2 2633.24
Total Expenditure 845.63 854.19 1084.84 1337.89 1677.77
Operating Profit 502.23 624.99 535.11 706.31 955.47
Other Income 36.76 33.56 48.79 85.56 139.17
Interest 16.42 6.39 4.13 3.56 7.18
Depreciation 63.46 74.15 78.21 81.96 94.59
Exceptional Items 0 0 0 -20 0
Profit Before Tax 459.11 578.01 501.56 686.36 992.87
Tax 145.51 164.29 180.45 234.45 220.01
Net Profit 313.61 413.73 321.11 451.91 772.86
Adjusted EPS (Rs.) 202.39 267.01 207.24 291.65 49.88

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 15.49 15.5 15.5 15.5 15.5
Total Reserves 1661.57 2074.32 2394.93 2846.62 3630.74
Borrowings 56.54 5.92 5.49 4.96 4.07
Other N/C liabilities 65.41 124.63 133.88 122.83 76.71
Current liabilities 287.29 253.38 378.55 532.68 359.02
Total Liabilities 2086.31 2473.75 2928.34 3522.58 4086.04
Assets
Net Block 787.88 871.58 842.64 928.74 968.1
Capital WIP 202.1 161.15 198.88 123.16 188.47
Investments 0.17 0 0 0 0
Loans & Advances 21.63 29.42 33.89 111.89 81.52
Other N/C Assets 2.62 3.45 1.95 1.33 1.66
Current Assets 1071.9 1408.15 1850.98 2357.46 2846.29
Total Assets 2086.31 2473.75 2928.34 3522.58 4086.04
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Profit Before Tax 459.11 578.01 501.56 686.36 992.87
Adjustment 68.72 70.69 50.94 76.12 32.15
Working Capital Changes -187.17 -10.86 -193.43 -353.95 -79.94
Tax Paid -116.56 -161.39 -157.14 -223.47 -244.14
Operating Cash Flow 224.09 476.46 201.93 185.06 700.94
Investing Cash Flow -11.91 -96.65 -358.84 -314.14 -766.08
Financing Cash Flow -92.9 -116.42 -3.59 -2.93 -6.87
Net Cash Flow 119.29 263.39 -160.5 -132.01 -72.01

Corporate Actions

Annual Reports

No Annual reports exist for this company.
Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.
Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.
Report us

Company News

X